These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 15527422)

  • 1. Quantitative determination of the binding of beta2-glycoprotein I and prothrombin to phosphatidylserine-exposing blood platelets.
    Bevers EM; Janssen MP; Comfurius P; Balasubramanian K; Schroit AJ; Zwaal RF; Willems GM
    Biochem J; 2005 Mar; 386(Pt 2):271-9. PubMed ID: 15527422
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-beta2 glycoprotein I antibodies prevent the De-activation of platelets and sustain their phagocytic clearance.
    Bondanza A; Sabbadini MG; Pellegatta F; Zimmermann VS; Tincani A; Balestrieri G; Manfredi AA; Rovere P
    J Autoimmun; 2000 Dec; 15(4):469-77. PubMed ID: 11090246
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of phosphatidylserine-dependent beta2-glycoprotein I macrophage interactions. Implications for apoptotic cell clearance by phagocytes.
    Balasubramanian K; Schroit AJ
    J Biol Chem; 1998 Oct; 273(44):29272-7. PubMed ID: 9786940
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-beta2-glycoprotein I antibodies in complex with beta2-glycoprotein I can activate platelets in a dysregulated manner via glycoprotein Ib-IX-V.
    Shi T; Giannakopoulos B; Yan X; Yu P; Berndt MC; Andrews RK; Rivera J; Iverson GM; Cockerill KA; Linnik MD; Krilis SA
    Arthritis Rheum; 2006 Aug; 54(8):2558-67. PubMed ID: 16868978
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immune clearance of phosphatidylserine-expressing cells by phagocytes. The role of beta2-glycoprotein I in macrophage recognition.
    Balasubramanian K; Chandra J; Schroit AJ
    J Biol Chem; 1997 Dec; 272(49):31113-7. PubMed ID: 9388264
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Beta2-glycoprotein I binding to platelet microparticle membrane specifically reduces immunoreactivity of glycoproteins IIb/IIIa.
    Vallar L; Regnault V; Latger-Cannard V; Lecompte T
    Thromb Haemost; 2001 Feb; 85(2):314-9. PubMed ID: 11246554
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Calpain-controlled detachment of major glycoproteins from the cytoskeleton regulates adhesive properties of activated phosphatidylserine-positive platelets.
    Artemenko EO; Yakimenko AO; Pichugin AV; Ataullakhanov FI; Panteleev MA
    Biochem J; 2016 Feb; 473(4):435-48. PubMed ID: 26607836
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biotinylation of glycan chains in beta2 glycoprotein I induces dimerization of the molecule and its detection by the human autoimmune anti-cardiolipin antibody EY2C9.
    Dupuy D'Angeac A; Stefas I; Graafland H; De Lamotte F; Rucheton M; Palais C; Eriksson AK; Bosc P; Rosé C; Chicheportiche R
    Biochem J; 2006 Jan; 393(Pt 1):117-27. PubMed ID: 16097953
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Microheterogeneity of beta-2 glycoprotein I: implications for binding to anionic phospholipids.
    Brighton TA; Dai YP; Hogg PJ; Chesterman CN
    Biochem J; 1999 May; 340 ( Pt 1)(Pt 1):59-67. PubMed ID: 10229659
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Strong correlation between the prevalence of cerebral infarction and the presence of anti-cardiolipin/beta2-glycoprotein I and anti-phosphatidylserine/prothrombin antibodies--Co-existence of these antibodies enhances ADP-induced platelet activation in vitro.
    Nojima J; Kuratsune H; Suehisa E; Kitani T; Iwatani Y; Kanakura Y
    Thromb Haemost; 2004 May; 91(5):967-76. PubMed ID: 15116258
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-beta 2-glycoprotein I autoantibodies from patients with the "antiphospholipid" syndrome bind to beta 2-glycoprotein I with low affinity: dimerization of beta 2-glycoprotein I induces a significant increase in anti-beta 2-glycoprotein I antibody affinity.
    Sheng Y; Kandiah DA; Krilis SA
    J Immunol; 1998 Aug; 161(4):2038-43. PubMed ID: 9712077
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phagocytosis of platelet microvesicles and beta2- glycoprotein I.
    Abdel-Monem H; Dasgupta SK; Le A; Prakasam A; Thiagarajan P
    Thromb Haemost; 2010 Aug; 104(2):335-41. PubMed ID: 20539917
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The prevalence of a non-phospholipid-binding form of beta2-glycoprotein I in human plasma--consequences for the development of anti-beta2-glycoprotein I antibodies.
    Horbach DA; van Oort E; Tempelman MJ; Derksen RH; de Groot PG
    Thromb Haemost; 1998 Nov; 80(5):791-7. PubMed ID: 9843173
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prothrombin is a cofactor for the binding of factor XI to the platelet surface and for platelet-mediated factor XI activation by thrombin.
    Baglia FA; Walsh PN
    Biochemistry; 1998 Feb; 37(8):2271-81. PubMed ID: 9485373
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oxidation and biotinylation of beta 2 glycoprotein I glycan chains induce an increase in its affinity for anionic phospholipids similar to that obtained by the addition of anti-beta 2 glycoprotein I or anti-cardiolipin antibodies.
    d'Angeac AD; Stefas I; Duperray C; Rucheton M; Graafland H; Montero JL; Chicheportiche R
    J Immunol Methods; 2005 May; 300(1-2):160-78. PubMed ID: 15904931
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phospholipid-bound beta 2-glycoprotein I induces the production of anti-phospholipid antibodies.
    Subang R; Levine JS; Janoff AS; Davidson SM; Taraschi TF; Koike T; Minchey SR; Whiteside M; Tannenbaum M; Rauch J
    J Autoimmun; 2000 Aug; 15(1):21-32. PubMed ID: 10936025
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activated scramblase and inhibited aminophospholipid translocase cause phosphatidylserine exposure in a distinct platelet fraction.
    Wolfs JL; Comfurius P; Rasmussen JT; Keuren JF; Lindhout T; Zwaal RF; Bevers EM
    Cell Mol Life Sci; 2005 Jul; 62(13):1514-25. PubMed ID: 15971000
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phosphatidylserine exposure and other apoptotic-like events in Bernard-Soulier syndrome platelets.
    Rand ML; Wang H; Bang KW; Teitel JM; Blanchette VS; Freedman J; Nurden AT
    Am J Hematol; 2010 Aug; 85(8):584-92. PubMed ID: 20658588
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Membrane binding of beta2-glycoprotein I can be described by a two-state reaction model: an atomic force microscopy and surface plasmon resonance study.
    Gamsjaeger R; Johs A; Gries A; Gruber HJ; Romanin C; Prassl R; Hinterdorfer P
    Biochem J; 2005 Aug; 389(Pt 3):665-73. PubMed ID: 15813706
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Distinguishing features of anti-beta2 glycoprotein I antibodies between patients with leprosy and the antiphospholipid syndrome.
    Arvieux J; Renaudineau Y; Mane I; Perraut R; Krilis SA; Youinou P
    Thromb Haemost; 2002 Apr; 87(4):599-605. PubMed ID: 12008941
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.